Ardsley Advisory Partners’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-209,039
Closed -$13M 140
2021
Q2
$13M Buy
209,039
+83,339
+66% +$5.55M 1.52% 19
2021
Q1
$8.19M Buy
+125,700
New +$8.2M 1% 29
2020
Q4
Sell
-17,598
Closed -$910K 157
2020
Q3
$910K Buy
17,598
+3,771
+27% +$194K 0.18% 71
2020
Q2
$681K Buy
13,827
+7,542
+120% +$407K 0.14% 70
2020
Q1
$320K Buy
+6,285
New +$362K 0.13% 73
2019
Q1
Sell
-6,285
Closed -$309K 138
2018
Q4
$309K Buy
+6,285
New +$357K 0.08% 83

Other funds holding EHC

Ardsley Advisory Partners's EHC Position: Q3 2021 in Review

Ardsley Advisory Partners sold out of Encompass Health (EHC) in Q3 2021, closing a stake of 209,039 shares — an estimated $13M sold.

Ardsley Advisory Partners first reported a position in EHC in Q4 2018 and held it in 6 quarters. The position peaked at $13M in Q2 2021. 435 funds tracked by Wall St. Rank hold EHC as of Q3 2021.

  • Ardsley Advisory Partners reported no remaining Encompass Health position as of Q3 2021 after selling out during the quarter.
  • Ardsley Advisory Partners sold 209,039 Encompass Health shares in Q3 2021, an estimated $13M.
  • Ardsley Advisory Partners first reported a position in Encompass Health in Q4 2018 and held it in 6 quarters.
  • Ardsley Advisory Partners's Encompass Health position peaked at $13M in Q2 2021.
  • 435 funds tracked by Wall St. Rank held Encompass Health as of Q3 2021.

Based on Ardsley Advisory Partners's 13F filing for Q3 2021, filed 15 Nov 2021.